Addressing Perinatal Substance Use Disorders through Primary Care

Thursday, October 30, 2025, 9:00 AM - 2:15 PM, Online


Maternal overdose—often linked to substance use during pregnancy and the first postpartum year—is a leading cause of maternal mortality in the United States. Addressing this crisis requires a coordinated, trauma-informed response across the healthcare continuum. While obstetric providers play a critical role, so too do pediatricians, primary care providers, addiction specialists, and behavioral health clinicians, who frequently encounter pregnant and parenting individuals during routine care. This CME event, jointly provided by Healthfirst and the Icahn School of Medicine at Mount Sinai, aims to equip healthcare professionals with evidence-based strategies to identify, treat, and support individuals with maternal substance use disorders (SUD). Through clinical updates, policy insights, and personal narratives, participants will explore the medical, developmental, and psychosocial dimensions of SUDs in pregnancy and postpartum, with an emphasis on reducing stigma and improving outcomes. Attendees will gain practical tools to enhance multidisciplinary collaboration, apply trauma-informed practices, and integrate evolving city and state policy guidance into their workflows to better support this high-risk population.

1. • Summarize diagnosis methods, treatment modalities, and management of used substances during the perinatal period (opioids & cannabis).
2. • Demonstrate collaboration between family medicine, obstetrics, pediatrics, addiction medicine, behavioral health, and peer support for comprehensive care of SUD in the perinatal period.
3. • Describe the PCP’s role in mitigating maternal mortality through early identification and collaboration with pediatricians and other primary care providers in addressing substance exposure in newborns and supporting maternal health post-delivery.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (4.50 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all accredited CE educational activities. All individuals in control of content of an activity accredited by ISMMS are expected to disclose all their financial relationships with ineligible companies existing within the prior 24 months. All relevant financial relationships have been mitigated and disclosed to learners before the activity takes place. 

Thursday, October 30, 2025